The Rise in Robotic Atypical Segmentectomies
ConditionLung Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorM.D. Anderson Cancer Center
About this trial
This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who underwent a lung resection from 2004 to 2019
Disqualifiers
None
Trial population
Patients who underwent a lung resection from 2004 to 2019
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Electronic Health Record Review
Other interventionReview of medical records
Treatment groups
600 Participants
are divided into 1 treatment groupGroup A: Observational (medical record review)1 intervention
Trial outcomes
Primary outcomes
1
Rate of change in robotic segmentectomies
Time frame
Up to 2 years2
Rate of typical and atypical segmentectomies
Time frame
Up to 2 years3
Differences in robotic versus other types of resections such as open and video-assisted thoracic surgery
Time frame
Up to 2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov